The firm's listing covers sector Healthcare, and focus areas Biotech, Clinical-stage Biotech, Drug Discovery and Genomics; listed stages are Growth and Series B.

Matthew Foy (CEO and Managing Partner) is listed as the contact to pitch at Avante Biocapital.

Frequently asked questions

What is Avante Biocapital?

Avante Biocapital is a venture capital firm based in -, Belgium, with a known portfolio of one company. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.

What does Avante Biocapital invest in?

Listed sectors include Healthcare; listed focus areas include Biotech, Clinical-stage Biotech, Drug Discovery and Genomics. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.

What stage does Avante Biocapital invest at?

Avante Biocapital is listed for Growth and Series B rounds in the database. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.

Who should I pitch at Avante Biocapital?

One person at Avante Biocapital is on file, listed as a contact for the firm, with their own profile page.

How do I contact Avante Biocapital?

Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The one person attached to the firm has their own page, which shows whether an address is on file for them.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal